UK markets open in 3 hours 24 minutes

Travere Therapeutics, Inc. (17R.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
17.300.00 (0.00%)
At close: 07:39PM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts5566
Avg. Estimate-0.54-0.78-2.9-2.85
Low estimate-0.78-0.88-3.25-4.16
High estimate0.17-0.64-2-1.48
Year ago EPS-0.44-0.48-1.52-2.9
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6678
Avg. Estimate60.93M50.31M212.79M204.1M
Low estimate47.4M45.65M195.08M179.62M
High estimate107.8M52.7M261.1M233M
Year ago sales47.85M50.98M198.32M212.79M
Sales growth (year/est)27.30%-1.30%7.30%-4.10%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.52-0.47-0.39-0.68
Actual EPS-0.44-0.48-0.96-0.64
Difference0.08-0.01-0.570.04
Surprise %15.40%-2.10%-146.20%5.90%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.54-0.78-2.9-2.85
7 days ago-0.54-0.78-2.9-2.85
30 days ago-0.68-0.75-3.01-2.7
60 days ago-0.67-0.76-3.05-2.9
90 days ago-0.67-0.76-3.06-2.91
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates17R.FIndustrySector(s)S&P 500
Current qtr.-22.70%N/AN/AN/A
Next qtr.-62.50%N/AN/AN/A
Current year-90.80%N/AN/AN/A
Next year1.70%N/AN/AN/A
Next 5 years (per annum)136.50%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A